Population Pharmacokinetics and Pharmacodynamics of Ontamalimab (SHP647), a Fully Human Monoclonal Antibody Against Mucosal Addressin Cell Adhesion Molecule‐1 (MAdCAM‐1), in Patients With Ulcerative Colitis or Crohn's Disease

Ontamalimab (SHP647) is a fully human, immunoglobulin G(2), antihuman mucosal addressin cell adhesion molecule‐1 (MAdCAM‐1) monoclonal antibody being developed for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). A population pharmacokinetic/pharmacodynamic (PK/PD) analysis wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yi, Marier, Jean‐Francois, Lavigne, Jean, Kassir, Nastya, Martin, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Non Covid Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318214/
https://www.ncbi.nlm.nih.gov/pubmed/32119128
http://dx.doi.org/10.1002/jcph.1590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318214/
https://www.ncbi.nlm.nih.gov/pubmed/32119128
http://dx.doi.org/10.1002/jcph.1590

Ejemplares similares